Antibacterial Drugs Market is valued around USD 45864.58 Million in 2017 and expected to reach USD 50204.61 Million by 2024 with the CAGR of 1.3% over the forecast period.
Antibacterial drugs are those drugs which can kill or inhibit the growth of microorganism such as bacteria, virus, fungi and others. Antibacterial drugs are mostly used for the treatment of prevention of infectious disease caused due to such microorganisms. There are various different class of antibacterial drugs available in the market according to the microorganisms. So, during the study of Global Antibacterial Drugs market, we have considered drug class and route of administration to analyze the market
Global Antibacterial drugs Market report is segmented on the basis of drug class, route of administration, distribution channel and by regional & country level. Based upon drug class, global antibacterial drugs Market is classified as B-lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, Phenicols, and Others. Based upon route of administration, global Antibacterial drugs Market is classified as Enteral, Parenteral and Others. Based upon distribution channel, global Antibacterial drugs Market is classified as Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Sales.
The regions covered in this Antibacterial drugs Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Antibacterial Drugs is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Browse The Full Report@ https://www.brandessenceresearch.com/pharmaceutical/antibacterial-drugs-market/
Key Players for Global Antibacterial Drugs Market Reports–
Global antibacterial drugs market report covers prominent players like Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Allergen Plc., Novartis Ag, AstraZeneca, Bayer AG, Merck & Co., Inc., Johnson and Johnson, Bristol Myers Squibb Company, and others.
Increase in the prevalence of infections disease and increased demand of novel drugs
The commercialization and growth of global antibacterial drugs market over the past 25 years has been highly impactful. One of the major factors driving the growth of antibacterial drugs market over the forecast period is increase in the prevalence of infectious disease over the period of time are expected to support the growth of antibacterial drugs market. As per Centers for Disease Control and Prevention 2017 report, around 16.8 million people in the U.S. visit physician office due to the infectious and parasitic diseases. Moreover, increased demand of efficient antibacterial drugs is also expected to support the growth of antibacterial drugs market. Increase in antibacterial resistance and increasing demand for novel drugs are expected to promote the growth of antibacterial drugs market. Furthermore, geriatric population is more prone to infectious disease due to the weak immune system and increase in geriatric population is expected to fuel the growth of antibacterial drugs market. However, increase use of generic drugs patent expiry is expected inhibit the growth of antibacterial drugs market over the forecast period.
North America is Expected to Dominate the Antibacterial Drugs Market
North America dominates the market with highest market share over the forecast period due to the increased prevalence of infectious disease coupled with high rate of diagnosis and treatment. Europe is expected to the second largest growing region over the forecast period due to the technological advancements and research and development activities leading to the innovation of novel drugs. Asia Pacific is expected to be the third largest and fastest growing region over the forecast period. Due to the increased awareness among people, large patient pool, increased prevalence of infectious disease and increase in per capita income are expected to promote the growth of antibacterial drugs market over the forecast period. Latin America, Middle East and Africa are expected to develop considerably over the forecast period.
Key Benefits for Global Antibacterial Drugs Market Reports –
- Global market report covers in depth historical and forecast analysis.
- Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global market report helps to identify opportunities in market place.
- Global market report covers extensive analysis of emerging trends and competitive landscape.
Antibacterial Drugs Market Segmentation –
By Drug Class
By Route of Administration
By Distribution Channel
- Hospital Pharmacies
- Drug Stores and Retail Pharmacies
- Online Sales
- North America
- Asia Pacific
- Southeast Asia
- Latin America
- Middle East and Africa
- Rest of Middle East and Africa
Antibacterial Drugs Market Key Players
GlaxoSmithKline Plc. (GSK)
Merck & Co., Inc.
Johnson and Johnson
Bristol Myers Squibb Company